Apyx Medical Corporation (APYX)

Apyx Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-18.71	-23.18	-15.17	-11.9	-19.71
Depreciation & Amortization	0.78	0.89	0.9	0.89	0.75
Share-Based Compensation	5.11	6.7	5.09	4.21	3.58
Other Operating Activities	7.57	-4.68	-1.27	-9.27	-3.1
Operating Cash Flow	-5.25	-20.28	-10.45	-16.07	-18.48
Capital Expenditures	6.73	-1.01	-0.72	-0.58	-1.3
Change in Investments	0	0	0	0	61.84
Investing Cash Flow	6.73	-1.01	-0.72	-0.58	60.54
Share Issuance / Repurchase	0.09	0.37	0.07	0.15	0.21
Debt Issued / Paid	31.93	-0.15	-0.24	-0.37	-0.06
Other Financing Activities	0.15	-	0.2	0.15	-
Financing Cash Flow	32.17	0.22	0.02	-0.07	0.15
Exchange Rate Effect	-0.19	0.4	0.1	-0.18	0
Net Cash Flow	33.46	-20.68	-11.05	-16.9	42.22
Free Cash Flow	1.49	-21.29	-11.17	-16.65	-19.78
Free Cash Flow Margin	2.84%	-47.83%	-23.03%	-60.07%	-70.04%
Free Cash Flow Per Share	0.04	-0.62	-0.33	-0.49	-0.58

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).